Antibody data
- Antibody Data
- Antigen structure
- References [24]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11114-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11114-1-AP, RRID:AB_2200201
- Product name
- TAP1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated TAP1 antibody (Cat. #11114-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy.
The herpesvirus UL49.5 protein hijacks a cellular C-degron pathway to drive TAP transporter degradation.
The proteome and transcriptome of stress granules and P bodies during human T lymphocyte activation.
The N-terminal Proline Hinge Motif Controls the Structure of Bovine Herpesvirus 1-encoded Inhibitor of the Transporter Associated with Antigen Processing Required for its Immunomodulatory Function.
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy.
ANGPTL2-mediated epigenetic repression of MHC-I in tumor cells accelerates tumor immune evasion.
Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells.
The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation.
Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma.
Antigen peptide transporters are upregulated in squamous cell carcinoma of the oral tongue and show sex-specific associations with survival.
Antigen Peptide Transporter 1 (TAP1) Promotes Resistance to MEK Inhibitors in Pancreatic Cancers.
Metabolomics of Acute vs. Chronic Spinach Intake in an Apc-Mutant Genetic Background: Linoleate and Butanoate Metabolites Targeting HDAC Activity and IFN-γ Signaling.
Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes.
Alveolar macrophages instruct CD8(+) T cell expansion by antigen cross-presentation in lung.
Noncoding RNA 886 alleviates tumor cellular immunological rejection in host C57BL/C mice.
microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients.
Expression of coproporphyrinogen oxidase is associated with detection of upper gastrointestinal carcinomas by 5-aminolevulinic acid-mediated photodynamic diagnosis.
Inducible TAP1 Negatively Regulates the Antiviral Innate Immune Response by Targeting the TAK1 Complex.
IRG1 increases MHC class I level in macrophages through STAT-TAP1 axis depending on NADPH oxidase mediated reactive oxygen species.
Characterization of the platelet granule proteome: evidence of the presence of MHC1 in alpha-granules.
Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes.
Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer.
Zhao Y, Liu Z, Deng K, Qu H, Zhang Q, Zhou P, Yang M, Yang X, Wang H, Li R, Xia J
International immunopharmacology 2024 May 10;132:111998
International immunopharmacology 2024 May 10;132:111998
The herpesvirus UL49.5 protein hijacks a cellular C-degron pathway to drive TAP transporter degradation.
Wąhalska M, Riepe C, Ślusarz MJ, Graul M, Borowski LS, Qiao W, Foltynska M, Carette JE, Bieńkowska-Szewczyk K, Szczesny RJ, Kopito RR, Lipińska AD
bioRxiv : the preprint server for biology 2023 Sep 27;
bioRxiv : the preprint server for biology 2023 Sep 27;
The proteome and transcriptome of stress granules and P bodies during human T lymphocyte activation.
Curdy N, Lanvin O, Cerapio JP, Pont F, Tosolini M, Sarot E, Valle C, Saint-Laurent N, Lhuillier E, Laurent C, Fournié JJ, Franchini DM
Cell reports 2023 Mar 28;42(3):112211
Cell reports 2023 Mar 28;42(3):112211
The N-terminal Proline Hinge Motif Controls the Structure of Bovine Herpesvirus 1-encoded Inhibitor of the Transporter Associated with Antigen Processing Required for its Immunomodulatory Function.
Graul M, Karska N, Wąchalska M, Krupa P, Ślusarz MJ, Lubocki M, Bieńkowska-Szewczyk K, Rodziewicz-Motowidło S, Sieradzan AK, Lipińska AD
Journal of molecular biology 2023 Mar 1;435(5):167964
Journal of molecular biology 2023 Mar 1;435(5):167964
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy.
Tu Z, Li K, Ji Q, Huang Y, Lv S, Li J, Wu L, Huang K, Zhu X
BMC cancer 2023 Feb 9;23(1):133
BMC cancer 2023 Feb 9;23(1):133
ANGPTL2-mediated epigenetic repression of MHC-I in tumor cells accelerates tumor immune evasion.
Kadomatsu T, Hara C, Kurahashi R, Horiguchi H, Morinaga J, Miyata K, Kurano S, Kanemaru H, Fukushima S, Araki K, Baba M, Linehan WM, Kamba T, Oike Y
Molecular oncology 2023 Dec;17(12):2637-2658
Molecular oncology 2023 Dec;17(12):2637-2658
Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells.
Tu J, Xu H, Ma L, Li C, Qin W, Chen X, Yi M, Sun L, Liu B, Yuan X
Theranostics 2022;12(2):747-766
Theranostics 2022;12(2):747-766
The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation.
Wang ZD, Tian X, Wang Y, Wang JJ, Ye SQ, Huang YQ, Qu YY, Chang K, Shi GH, Ye DW, Gu CY
Frontiers in oncology 2022;12:1013790
Frontiers in oncology 2022;12:1013790
Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma.
Li Y, Hong YK, Wang X, Pandit H, Zheng Q, Yu Y, Shi X, Chen Y, Tan M, Pulliam Z, Bhutiani N, Lin A, Badach J, Zhang P, Martin RC
Clinical & translational immunology 2022;11(12):e1430
Clinical & translational immunology 2022;11(12):e1430
Antigen peptide transporters are upregulated in squamous cell carcinoma of the oral tongue and show sex-specific associations with survival.
Attaran N, Coates PJ, Zborayova K, Erdogan B, Magan M, Sgaramella N, Nylander K, Gu X
Oncology letters 2022 Nov;24(5):390
Oncology letters 2022 Nov;24(5):390
Antigen Peptide Transporter 1 (TAP1) Promotes Resistance to MEK Inhibitors in Pancreatic Cancers.
Li B, Feng Y, Hou Q, Fu Y, Luo Y
International journal of molecular sciences 2022 Jun 28;23(13)
International journal of molecular sciences 2022 Jun 28;23(13)
Metabolomics of Acute vs. Chronic Spinach Intake in an Apc-Mutant Genetic Background: Linoleate and Butanoate Metabolites Targeting HDAC Activity and IFN-γ Signaling.
Chen YS, Li J, Neja S, Kapoor S, Tovar Perez JE, Tripathi C, Menon R, Jayaraman A, Lee K, Dashwood WM, Wang S, Zhang K, Kobayashi K, Rajendran P, Dashwood R
Cells 2022 Feb 7;11(3)
Cells 2022 Feb 7;11(3)
Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes.
Asleh K, Negri GL, Spencer Miko SE, Colborne S, Hughes CS, Wang XQ, Gao D, Gilks CB, Chia SKL, Nielsen TO, Morin GB
Nature communications 2022 Feb 16;13(1):896
Nature communications 2022 Feb 16;13(1):896
Alveolar macrophages instruct CD8(+) T cell expansion by antigen cross-presentation in lung.
Kawasaki T, Ikegawa M, Yunoki K, Otani H, Ori D, Ishii KJ, Kuroda E, Takamura S, Kitabatake M, Ito T, Isotani A, Kawai T
Cell reports 2022 Dec 13;41(11):111828
Cell reports 2022 Dec 13;41(11):111828
Noncoding RNA 886 alleviates tumor cellular immunological rejection in host C57BL/C mice.
Ma H, Wang M, Zhou Y, Yang JJ, Wang LY, Yang RH, Wen MJ, Kong L
Cancer medicine 2020 Jul;9(14):5258-5271
Cancer medicine 2020 Jul;9(14):5258-5271
microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients.
Mari L, Hoefnagel SJM, Zito D, van de Meent M, van Endert P, Calpe S, Sancho Serra MDC, Heemskerk MHM, van Laarhoven HWM, Hulshof MCCM, Gisbertz SS, Medema JP, van Berge Henegouwen MI, Meijer SL, Bergman JJGHM, Milano F, Krishnadath KK
Gastroenterology 2018 Sep;155(3):784-798
Gastroenterology 2018 Sep;155(3):784-798
Expression of coproporphyrinogen oxidase is associated with detection of upper gastrointestinal carcinomas by 5-aminolevulinic acid-mediated photodynamic diagnosis.
Ogihara K, Isomoto H, Kurumi H, Kanda T, Hashisako M, Tabata K, Ishii H, Ohnita K, Yamaguchi N, Akazawa Y, Matsushima K, Takeshima F, Kunizaki M, Hidaka S, Nanashima A, Fukuoka J, Nagayasu T, Nakao K
Photodiagnosis and photodynamic therapy 2017 Sep;19:15-21
Photodiagnosis and photodynamic therapy 2017 Sep;19:15-21
Inducible TAP1 Negatively Regulates the Antiviral Innate Immune Response by Targeting the TAK1 Complex.
Xia Z, Xu G, Yang X, Peng N, Zuo Q, Zhu S, Hao H, Liu S, Zhu Y
Journal of immunology (Baltimore, Md. : 1950) 2017 May 1;198(9):3690-3704
Journal of immunology (Baltimore, Md. : 1950) 2017 May 1;198(9):3690-3704
IRG1 increases MHC class I level in macrophages through STAT-TAP1 axis depending on NADPH oxidase mediated reactive oxygen species.
Liu X, Wu XP, Zhu XL, Li T, Liu Y
International immunopharmacology 2017 Jul;48:76-83
International immunopharmacology 2017 Jul;48:76-83
Characterization of the platelet granule proteome: evidence of the presence of MHC1 in alpha-granules.
Zufferey A, Schvartz D, Nolli S, Reny JL, Sanchez JC, Fontana P
Journal of proteomics 2014 Apr 14;101:130-40
Journal of proteomics 2014 Apr 14;101:130-40
Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
Zhao X, Sun Q, Tian H, Cong B, Jiang X, Peng C
Asian Pacific journal of cancer prevention : APJCP 2011;12(10):2741-5
Asian Pacific journal of cancer prevention : APJCP 2011;12(10):2741-5
Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
Qifeng S, Bo C, Xingtao J, Chuanliang P, Xiaogang Z
The Journal of thoracic and cardiovascular surgery 2011 Mar;141(3):808-14
The Journal of thoracic and cardiovascular surgery 2011 Mar;141(3):808-14
The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes.
Bartoszewski R, Brewer JW, Rab A, Crossman DK, Bartoszewska S, Kapoor N, Fuller C, Collawn JF, Bebok Z
The Journal of biological chemistry 2011 Dec 2;286(48):41862-41870
The Journal of biological chemistry 2011 Dec 2;286(48):41862-41870
Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer.
Kasajima A, Sers C, Sasano H, Jöhrens K, Stenzinger A, Noske A, Buckendahl AC, Darb-Esfahani S, Müller BM, Budczies J, Lehman A, Dietel M, Denkert C, Weichert W
Human pathology 2010 Dec;41(12):1758-69
Human pathology 2010 Dec;41(12):1758-69
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HepG2 cells were subjected to SDS PAGE followed by western blot with 11114-1-AP( TAP1 Antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using TAP1 antibody 11114-1-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red). Blue pseudocolor = DAPI (fluorescent DNA dye).
- Sample type
- cell line